This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genzyme Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hervé Husson - Innovator in Ciliopathy Treatment
Hervé Husson is an inventor based in Bridgewater, NJ (US). He is currently associated with Genzyme Corporation, where he contributes to advancements in medical treatments. Although he has not yet been granted any patents, his work is focused on innovative solutions for health-related challenges.
Latest Patent Applications
Hervé Husson's notable patent application is titled "Treatment of Ciliopathies Using Inhibitors of Glucosylceramide Synthase (GCS)." This application relates to a method of treating a ciliopathy in a subject. The method involves administering an effective amount of a quinuclidine compound to the subject. Additionally, the application discloses a pharmaceutical composition comprising a quinuclidine compound for use in this treatment method.
Conclusion
Hervé Husson is making significant strides in the field of medical innovation, particularly in the treatment of ciliopathies. His ongoing research and patent applications reflect his commitment to improving health outcomes through inventive solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile